JPMorgan plans autocallable contingent interest notes linked to Endo

By Angela McDaniels

Tacoma, Wash., March 18 - JPMorgan Chase & Co. plans to price autocallable contingent interest notes due April 8, 2015 linked to the common stock of Endo Health Solutions Inc., according to an FWP filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a coupon at an annual rate 13% if Endo shares close at or above the trigger level, 65% of the initial share price, on the review date for that quarter.

The notes will be called at par plus the contingent coupon if Endo shares close at or above the initial share price on any quarterly review date other than the final review date.

If the notes have not been called and the stock finishes at or above the trigger level, the payout at maturity will be par plus the contingent coupon. Otherwise, investors will be fully exposed to the stock's decline.

J.P. Morgan Securities LLC is the agent.

The notes are expected to price March 21 and settle March 26.

The Cusip number is 48127DCB2.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.